/Home/Global/Private Equity: Buyouts: High-end Capability in USA/Debevoise & Plimpton LLP
View profile of Debevoise & Plimpton LLP
Department profile
Debevoise & Plimpton LLP
Department profile | Debevoise & Plimpton LLP
Private Equity: Buyouts: High-end Capability

Chambers Review

Provided by Chambers
Private Equity: Buyouts: High-end Capability - USA
2
Band 2
What the team is known for

Debevoise & Plimpton LLP is experienced in a significant array of US and cross-border buyouts, often working with high-level funds and target corporations. Brings to bear an integrated global practice, able to provide support in areas such as tax, litigation and corporate governance. Demonstrates considerable strength in the healthcare sector, with notable experience handling investments into drug, device and wider consumer product manufacturers.

Notable practitioners

New York-based Kevin Schmidt is a key contact at the firm.

Work Highlights

Provided by Debevoise & Plimpton LLP
  • Debevoise & Plimpton LLP advised Clayton Dubilier & Rice on the acquisition of a majority stake in Roper Technologies for $3.7 billion.

Strengths

Provided by Chambers

"They're trusted advisers with real commercial sense."

Private Equity: Buyouts: High-end Capability respondent
Global